• 1
    Sisson D. Acquired valvular heart disease in dogs and cats, in BonaguraJ. ed, Cardiology, Contemporary Issues in Small Animal Practice. New York , NY , Churchill Livingston, 1987;59116.
  • 2
    Ettinger SJ. Valvular heart disease, in EttingerSJ ed, Textbook of Veterinary Internal Medicine, 2nd ed. Philadelphia , PA : WB Saunders; 1983;959973.
  • 3
    Fox PR. Canine myocardial disease. In: FoxPR, ed. Canine and Feline Cardiology. New York , NY : Churchill Livingston; 1988;467482.
  • 4
    Whitney JC. Observations on the effect of age on the severity of heart valve lesions in the dog. J Small Animal Pract 1974;15: 511522.
  • 5
    Keene BW. Canine cardiomyopathy. In: KirkRW, ed. Current Veterinary Therapy X, Philadelphia , PA : WB Saunders; 1989;240251.
  • 6
    Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1993;71:3C11C.
  • 7
    Ware WA, Lund DD, Subieta AR, et al. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral disease and dilated cardiomyopathy. J Am Vet Med Assoc 1990;197:14751481.
  • 8
    Braunwald E. ACE inhibitors—A cornerstone of the treatment of heart failure. N Engl J Med 1991;325:351353.
  • 9
    Cohn JN, Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303310.
  • 10
    Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316: 14291435.
  • 11
    Giles T. Enalapril in the treatment of congestive heart failure. J Cardiovasc Pharmacol 1990;15 (suppl 3):S6S10.
  • 12
    SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293302.
  • 13
    Swedberg K., Eneroth P., Kjekshus J., et al. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (Follow-up of the Consensus Trial). Am J Cardiol 1990;66:40D45D.
  • 14
    Tocco DJ, DeLuna AE, Duncan AEW, et al. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab Dispos 1982;10:1519.
  • 15
    Sahn DJ, DeMaria A., Kisslo J., et al. Recommendations regarding quantitation in M-mode echocardiograph: Results of a survey of echocardiographic measurements. Circ 1978;58:10721083.
  • 16
    Puri, ML. On the combination of independent two sample tests of a general class. Rev Intl Stat Instit 1965;33:229241.
  • 17
    Puri, ML. The van Elteren W test and non-null hypothesis. Rev Intl Stat Instit 1969;37:166175.
  • 18
    Atkins CE, Snyder PS. Systolic time intervals and their derivatives for evaluation of cardiac function. J Vet Int Med 1992;6: 5563.
  • 19
    Sisson D. The clinical assessment of cardiac function, In: EttingerSJ, ed. Textbook of Veterinary Internal Medicine (3rd ed), Philadelphia , PA : W.B. Saunders; 1989;923938.